Northcoast analyst Keith Housum downgraded Axon (AXON) to Neutral from Buy, stating that Axon’s “partner turned competitor” is “turning into a pain.”
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXON: